| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8430399 | Biology of Blood and Marrow Transplantation | 2018 | 10 Pages |
Abstract
- After antithymocyte globulin (ATG) therapy, there is a high incidence of severe acute hepatotoxicity (SAH).
- The incidence of SAH is particularly high with regimens containing both ATG and busulfan.
- The impact of SAH post-ATG seems limited and normally resolves without sequelae.
- SAH should not lead to interruptions in the planned conditioning therapy.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Walter J.F.M. van der Velden, Esther C. de Weerd-de Jong, Anton F.J. de Haan, Nicole M.A. Blijlevens,